Autres langues Jazz Pharmaceuticals plc

Actions

JAZZ

IE00B4Q5ZN47

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 15/07/2024			Varia. 5j.	Varia. 1 janv.
103,3 ^USD	-2,13 %		+2,60 %	-15,99 %

10/07	Jazz Pharmaceuticals plc promeut Samantha Pearce au poste de Chief Commercial Officer	CI
20/06	JAZZ PHARMACEUTICALS PLC : Needham & Co. persiste à l'achat	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Jazz Pharmaceuticals Hosts Discussion of Healthcare Inequities in the U.S. To Honor Juneteenth	15/07
Jazz Pharmaceuticals plc Promotes Samantha Pearce to Chief Commercial Officer	10/07
Jazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer	09/07
Jazz Pharmaceuticals Publishes 2023 Corporate Sustainability and Social Impact Report: Progress, Responsibility and Innovation	08/07
Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell 3000E Growth Index	01/07
Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell 1000 Growth Index	01/07
Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell Midcap Growth Index	01/07
Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell 3000 Growth Index	01/07
Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell Small Cap Comp Growth Index	01/07
Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell 2500 Growth Index	01/07
Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	20/06
Sector Update: Health Care	20/06
Jazz Pharmaceuticals Says Phase 2b Trial for Suvecaltamide Misses Primary Endpoint -- Shares Slump Pre-Bell	20/06
Jazz Pharmaceuticals' tremor drug fails to meet main goal in mid-stage study	20/06
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor	20/06
Jazz Pharmaceuticals plc Provides Update on Phase 2b Trial of Investigational Suvecaltamide in Essential Tremor	20/06
Jazz Pharmaceuticals : 2023 Annual Report	15/06
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)	11/06
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024	01/06
Jazz Pharmaceuticals plc Announces Catherine Sohn, Pharm.D. Will Not Stand for Re-Election to the Board	31/05

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Jazz Pharmaceuticals plc

Actions

JAZZ

IE00B4Q5ZN47

Autres langues

Filtres